Anti-Counterfeiting Trade Agreement Seeks To Exclude Patent Enforcement
Executive Summary
When the U.S. and other countries began negotiating the terms of the Anti-Counterfeiting Trade Agreement, the generic industry was worried that it might be used to expand the rights of patent owners.
You may also be interested in...
Intellectual Property Bill Would Sanction Countries That Fail U.S. Rules
A Senate bill would block bank loans to countries that fail to implement intellectual property protections mandated by the U.S. government
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.
Current Pathways For Rare Disease Drugs Are Not Optimal, US FDA’s Califf Says
Anticipating a ‘tsunami of therapies’ for rare diseases, commissioner says the agency will have to think of creative approaches and employ regulatory flexibility for them. FDA considers copying the oncology center’s Project Facilitate for expanded access to other diseases.